Long-term CPAP treatment improves asthma control in patients with asthma and obstructive sleep apnoea
Both asthma and obstructive sleep apnoea cause sleep disturbance, daytime sleepiness and diminished quality of life. Continuous positive airway pressure (CPAP) is efficient in reducing symptoms related to sleep apnoea. Here we report the impact of long-term use of CPAP on asthma symptoms.
A survey questionnaire was distributed to all of our obstructive sleep apnoea patients with CPAP therapy in 2013. We used the Finnish version of the Asthma Control Test™ (ACT) and a visual analogue scale (0 = no symptoms, 100 = severe asthma symptoms). Asthma was defined as self-reported physician-diagnosed disease and a special reimbursement for asthma medication by the Social Insurance Institution.
We sent 2577 questionnaires and received 1586 answers (61 %). One hundred ninety-seven patients were asthmatics with a prevalence of asthma among CPAP users of 13 %. We studied 152 patients (58 females) whose CPAP therapy was initiated after starting asthma medication. Their mean (SD) age was 62 (10) years, duration of CPAP 5.7 (4.7) years and their CPAP daily use was 6.3 (2.4) h. Self-reported asthma severity decreased significantly from 48.3 (29.6) to 33.1 (27.4) (p < 0.001), and ACT score increased significantly from 15.35 (5.3) to 19.8 (4.6) (p < 0.001) without a significant change in the body mass index (BMI). The percentage of patients using rescue medication daily reduced from 36 to 8 % with CPAP (P < 0.001).
We noticed a significant decrease in asthma symptoms with long-term use of CPAP in patients with both asthma and obstructive sleep apnoea.
KeywordsAsthma Obstructive sleep apnoea CPAP
PK and AB had full access to all of the data and contributed substantially to the study design, data analysis and interpretation and the writing of the manuscript. PB had full access to data and contributed substantially to the data analysis and writing of the manuscript. PM contributed substantially to the study design, data interpretation and the writing of the manuscript.
Compliance with ethical standards
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
The Helsinki University Special Fund provided financial support in the form of research grant funding. The sponsor had no role in the design or conduct of this research.
Conflict of interest
All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent licensing arrangements) or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.
Informed consent was obtained from all individual participants included in the study.
- 4.Teodorescu M, Broytman O, Curran-Everett D, Sorkness RL, Crisafi G, Bleecker ER, Erzurum S, Gaston BM, Wenzel SE, Jarjour NN, National Institutes, National Heart, Lung and Blood Institute Severe Asthma Research Program (SARP) Investigators (2015) Obstructive sleep apnea risk, asthma burden, and lower airway inflammation in adults in the Severe Asthma Research Program (SARP) II. J Allergy Clin Immunol Pract 3:566–75.e1. doi: 10.1016/j.jaip.2015.04.002 CrossRefPubMedPubMedCentralGoogle Scholar
- 8.Luyster FS, Teodorescu M, Bleecker E, Busse W, Calhoun W, Castro M, Chung KF, Erzurum S, Israel E, Strollo PJ, Wenzel SE (2012) Sleep quality and asthma control and quality of life in non-severe and severe asthma. Sleep Breath 16:1129–1137. doi: 10.1007/s11325-011-0616-8 CrossRefPubMedGoogle Scholar
- 10.Reddel HK, Taylor DR, Bateman ED, et al. (2009) American Thoracic Society/European Respiratory Society Task Force on asthma control and exacerbations. an official American Thoracic Society/European Respiratory Society Statement: asthma control and exacerbations. Am J Respir Crit Care Med 180:59–99. doi: 10.1164/rccm.200801-060ST CrossRefPubMedGoogle Scholar
- 12.Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J (2005) Standardisation of spirometry. ATS/ERS Task Force. Eur Respir J 26:319–338CrossRefPubMedGoogle Scholar
- 15.American Academy of Sleep Medicine (2014) International classification of sleep disorders, 3rd edn. Darien, IllinoisGoogle Scholar
- 24.Jantunen J, Kauppi P, Linna M, Martikainen J, Mäkelä M, Pelkonen A, Haahtela T (2014) Astman ja allergian kustannukset ovat suuret, mutta laskussa. (the costs of asthma and allergy are large but are decreasing. In Finnish). Finn Med J 9:641–647Google Scholar
- 29.Holguin F, Bleecker ER, Busse WW, Calhoun WJ, Castro M, Erzurum SC, Fitzpatrick AM, Gaston B, Israel E, Jarjour NN, Moore WC, Peters SP, Yonas M, Teague WG, Wenzel SE (2011) Obesity and asthma: an association modified by age of asthma onset. J Allergy Clin Immunol 127:1486–93. e2. doi: 10.1016/j.jaci.2011.03.036 CrossRefPubMedPubMedCentralGoogle Scholar